Ipilimumab Can Be Infused Safely Over 30 Minutes

Share this content:
Ipilimumab at a dose of 3 mg/kg can be infused safely over 30 minutes with an acceptably low incidence of infusion-related reactions.
Ipilimumab at a dose of 3 mg/kg can be infused safely over 30 minutes with an acceptably low incidence of infusion-related reactions.

Ipilimumab at a dose of 3 mg/kg can be infused safely over 30 minutes, rather than 90 minutes, with an acceptably low incidence of infusion-related reactions, a new study published online ahead of print in the Journal of Clinical Oncology has shown.

Because ipilimumab at a dose of 10 mg/kg has been infused over 90 minutes in clinical trials, researchers sought to investigate the safety of infusing ipilimumab at a dose of 3 mg/kg over 30 minutes.

For the study, researchers at Memorial Sloan-Kettering Cancer Center in New York, NY, retrospectively evaluated the incidence of infusion-related reactions at Memorial Sloan-Kettering in 595 patients who received ipilimumab at a dose of 3 or 10 mg/kg infused over 90 minutes.

Results showed that 595 patients received 2,507 3 mg/kg or 10 mg/kg doses of ipilimumab infused over 90 minutes.

Researchers found that 4.3% of patients who received 10 mg/kg experienced infusion-related reactions compared with 2.2% of those who received 3 mg/kg (P=0.22).

RELATED: Increased Risk of Infusion Site Reactions with Fosaprepitant in Patients Receiving Anthracyclines

Researchers then prospectively evaluated 120 patients treated with ipilimumab 3 mg/kg infused over 30 minutes. Of those, seven (5.8%) patients experienced an infusion-related reaction (P=0.06 versus 90-minute infusion).

The study also demonstrated that after an infusion-related reaction, patients can safely receive subsequent doses of ipilimumab with premedication.

Reference

  1. Momtaz P, Park V, Panageas S, et al. Safety of infusing ipilimumab over 30 minutes. J Clin Oncol. 2015. [epub ahead of print]. doi: 10.1200/JCO.2015.61.0030.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters